skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi, I am a holder and have had the recent pleasure of walking through the Sangoma Proxy materials and have read more about the deal with StarBlue and I'm wondering your thoughts of the transaction, specifically around the details that the StarBlue CEO will be THE major holder of Sangoma (25%). I understand that Sangoma is using their much better capital position to expand and magically double their revenue and garner much more SaaS ARR, however, it feels like the StarBlue organization was far less diligent in their balance sheet management and overall operations. Do you feel the Sangoma management will actually be able to exert their clearly quite strong operational 'chops' on StarBlue? It sort of feels like a reverse buy; As in, StarBlue convinced Sangoma to 'buy' them and thus give them capital, but the actual ownership is with StarBlue.
Read Answer Asked by Allan on March 12, 2021
Q: I would appreciate your comments of the latest acquisition, Vend.
“Vend generated revenue of approximately $34 million and GTV3 of more than $7 billion in the trailing twelve month period ending December 31st, 2020. Lightspeed will acquire Vend for total estimated consideration of approximately $350 million, satisfied by way of payment on closing of approximately $192.5 million in cash and the issuance of subordinate voting shares in the capital of Lightspeed valued at approximately $157.5 million. The deal, which is subject to customary closing conditions and post-closing working capital adjustment, is expected to close towards the end of April, subject to the receipt of applicable regulatory approvals.”
As always - many thanks.
Clayton
Read Answer Asked by Clayton on March 12, 2021
Q: One of the "highlights" from Kinaxis' recent quarter was the decline in gross profit. From what I can tell, it seems that R&D spending was significantly higher, in part to augment AI capabilities. Can you shed any light on this decrease in profit and if it was from higher R&D is that not a good use of capital and does that not bode well for the company going forward?

Appreciate your insight.

Paul F.
Read Answer Asked by Paul on March 12, 2021
Q: Hello Peter, Ryan, and Team,

Wondering if you think it's still worth putting some money into the re-opening trade via one of the airlines. I'm considering reducing my position in REAL in order to do so. Although REAL is relatively cheap right now, its price trend is still moving lower. I know you like Southwest Airlines, but Air Canada's share price is nowhere near pre-pandemic levels, while LUV is already there. I have been reluctant to invest in the airlines, as I'm convinced that business travel will never return to the same levels. Many companies have finally realized it's often unnecessary and that cost-effective, technology-based alternatives are preferred. However, I think the pent-up leisure travel demand will likely make up for this on a short-term basis. Can I please have your thoughts?
Thank you.
Brad
Read Answer Asked by Bradley on March 12, 2021
Q: So working in the finance industry, when it comes to business valuation, I know private health clinics get very low multiples. If Well is continues to consolidate in a space where now one else is and provides technological efficiencies. Even if they are just able to capture the majority of market share in Canada, could the potential upside be the sky?
Read Answer Asked by James on March 11, 2021
Q: Hi 5i team,
This is not a question. Regarding the book value of TOI , it's best to confirm with CSU. Apparently, the book value for the stock distribution is indeed close to zero per CSU client relation.
Read Answer Asked by Willie on March 10, 2021
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!